These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 8641476)

  • 21. Purification and molecular cloning of a major antibacterial protein of the protozoan parasite Entamoeba histolytica with lysozyme-like properties.
    Jacobs T; Leippe M
    Eur J Biochem; 1995 Aug; 231(3):831-8. PubMed ID: 7649184
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Pore-forming polypeptides of the pathogenic protozoon Naegleria fowleri.
    Herbst R; Ott C; Jacobs T; Marti T; Marciano-Cabral F; Leippe M
    J Biol Chem; 2002 Jun; 277(25):22353-60. PubMed ID: 11948186
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Ancient weapons: the three-dimensional structure of amoebapore A.
    Leippe M; Bruhn H; Hecht O; Grötzinger J
    Trends Parasitol; 2005 Jan; 21(1):5-7. PubMed ID: 15639732
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Isolation, characterization and partial purification of a transferable membrane channel (amoebapore) produced by Entamoeba histolytica.
    Rosenberg I; Bach D; Loew LM; Gitler C
    Mol Biochem Parasitol; 1989 Mar; 33(3):237-47. PubMed ID: 2468084
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Sequence requirements for the activity of membrane-active peptides.
    Werkmeister JA; Hewish DR; Kirkpatrick A; Rivett DE
    J Pept Res; 2002 Oct; 60(4):232-8. PubMed ID: 12366530
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Interaction of amoebapores and NK-lysin with symmetric phospholipid and asymmetric lipopolysaccharide/phospholipid bilayers.
    Gutsmann T; Riekens B; Bruhn H; Wiese A; Seydel U; Leippe M
    Biochemistry; 2003 Aug; 42(32):9804-12. PubMed ID: 12911324
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Ancient weapons for attack and defense: the pore-forming polypeptides of pathogenic enteric and free-living amoeboid protozoa.
    Leippe M; Herbst R
    J Eukaryot Microbiol; 2004; 51(5):516-21. PubMed ID: 15537085
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cell-free synthesis and combinatorial selective 15N-labeling of the cytotoxic protein amoebapore A from Entamoeba histolytica.
    Xun Y; Tremouilhac P; Carraher C; Gelhaus C; Ozawa K; Otting G; Dixon NE; Leippe M; Grötzinger J; Dingley AJ; Kralicek AV
    Protein Expr Purif; 2009 Nov; 68(1):22-7. PubMed ID: 19573603
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Pore-forming peptide of pathogenic Entamoeba histolytica.
    Leippe M; Ebel S; Schoenberger OL; Horstmann RD; Müller-Eberhard HJ
    Proc Natl Acad Sci U S A; 1991 Sep; 88(17):7659-63. PubMed ID: 1881907
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Spontaneous release of cysteine proteinases but not of pore-forming peptides by viable Entamoeba histolytica.
    Leippe M; Sievertsen HJ; Tannich E; Horstmann RD
    Parasitology; 1995 Dec; 111 ( Pt 5)():569-74. PubMed ID: 8559589
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Comparative modeling of amoebapores and granulysin based on the NK-lysin structure-structural and functional implications.
    Bruhn H; Leippe M
    Biol Chem; 1999; 380(7-8):1001-7. PubMed ID: 10494853
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effects of the hinge region of cecropin A(1-8)-magainin 2(1-12), a synthetic antimicrobial peptide, on liposomes, bacterial and tumor cells.
    Shin SY; Kang JH; Jang SY; Kim Y; Kim KL; Hahm KS
    Biochim Biophys Acta; 2000 Feb; 1463(2):209-18. PubMed ID: 10675500
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cyclization of a cytolytic amphipathic alpha-helical peptide and its diastereomer: effect on structure, interaction with model membranes, and biological function.
    Oren Z; Shai Y
    Biochemistry; 2000 May; 39(20):6103-14. PubMed ID: 10821683
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Novel putative saposin-like proteins of Entamoeba histolytica different from amoebapores.
    Bruhn H; Leippe M
    Biochim Biophys Acta; 2001 Sep; 1514(1):14-20. PubMed ID: 11513801
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Inhibition of antibody producing cells (PFC) from Peyer patches by glycoproteins from Entamoeba histolytica.
    Campos Rodríguez R; Castañeda Ibarra F; García Montoya R; Lara Padilla E; García Latorre E
    Rev Latinoam Microbiol; 1991; 33(2-3):165-70. PubMed ID: 1670482
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Potency of amoebapores compared to that of other membrane-permeating peptides.
    Andrä J; Berninghausen O; Leippe M
    Arch Med Res; 1997; 28 Spec No():156-7. PubMed ID: 9033052
    [No Abstract]   [Full Text] [Related]  

  • 37. Amoebapore homologs of Caenorhabditis elegans.
    Bányai L; Patthy L
    Biochim Biophys Acta; 1998 Dec; 1429(1):259-64. PubMed ID: 9920402
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Purification and partial characterization of an hemolytic activity from Entamoeba histolytica.
    Rosales-Encina JL; Schlie-Guzmán MA; Jiménez-Delgadillo B; Talamás-Rohana P; Matluk MR
    Arch Med Res; 1992; 23(2):243-8. PubMed ID: 1340304
    [TBL] [Abstract][Full Text] [Related]  

  • 39. An ion-channel forming protein produced by Entamoeba histolytica.
    Lynch EC; Rosenberg IM; Gitler C
    EMBO J; 1982; 1(7):801-4. PubMed ID: 6329705
    [TBL] [Abstract][Full Text] [Related]  

  • 40. NMR derived solution structure of an EF-hand calcium-binding protein from Entamoeba Histolytica.
    Atreya HS; Sahu SC; Bhattacharya A; Chary KV; Govil G
    Biochemistry; 2001 Dec; 40(48):14392-403. PubMed ID: 11724551
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.